| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | paricalcitol | FAERS: 5 | US FAERS | |
| 2 | Cinacalcet | FAERS: 3 | US FAERS | |
| 3 | ambrisentan | FAERS: 3 | US FAERS | |
| 4 | Tacrolimus | FAERS: 2 | US FAERS | |
| 5 | teduglutide | FAERS: 2 | US FAERS | |
| 6 | Clindamycin | FAERS: 1 | US FAERS | |
| 7 | Everolimus | FAERS: 1 | US FAERS | |
| 8 | PCI 32765 | FAERS: 1 | US FAERS | |
| 9 | Prednisolone | FAERS: 1 | US FAERS | |
| 10 | Pregabalin | FAERS: 1 | US FAERS | |
| 11 | Risedronic Acid | FAERS: 1 | US FAERS | |
| 12 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 13 | tofacitinib | FAERS: 1 | US FAERS | |
| 14 | Octreotide | Canada Vigilance: 2 | Canada Vigilance | |
| 15 | pirfenidone | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.